Transcriptomic insights into multiple system atrophy from a PLP-α-synuclein transgenic mouse model

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Multiple system atrophy (MSA) is a rare, rapidly progressive neurodegenerative disorder characterized by α-synuclein aggregation in oligodendrocytes.
• The exact cause of MSA remains unknown, leading to limited treatment options and poor patient outcomes.

Purpose of the Study:

• To investigate differentially expressed genes (DEGs) in a validated PLP-α-synuclein transgenic mouse model of MSA.
• To identify potential gene expression profiles relevant to human MSA for understanding disease mechanisms and developing therapeutic strategies.

Main Methods:

• RNA sequencing was performed on brain samples from PLP-α-synuclein transgenic mice and wild-type (WT) controls.
• Differentially expressed genes (DEGs) were identified and analyzed for pathway enrichment.
• Overlap analysis was conducted between mouse DEGs and previously profiled human MSA RNA data.

Main Results:

• A total of 40 DEGs were identified in the PLP group compared to WT mice.
• Upregulated genes were enriched in immune and endothelial cell pathways.
• Downregulated genes were enriched in oligodendrocyte and neuronal pathways, with significant downregulation of the Tsr2 gene observed in human MSA overlap analysis.

Conclusions:

• Gene expression profiling in an MSA mouse model reveals significant alterations in immune, endothelial, oligodendrocyte, and neuronal pathways.
• The identification of specific DEGs, including the downregulated Tsr2 gene in human MSA, provides crucial insights into MSA pathogenesis.
• These findings are vital for advancing the understanding of MSA causes and developing potential preventative or therapeutic interventions.